S&P 500   3,322.57 (+0.17%)
DOW   29,319.84 (+0.08%)
QQQ   222.43 (+0.07%)
AAPL   315.89 (+0.21%)
MSFT   165.52 (-0.39%)
GOOGL   1,464.15 (+0.96%)
AMZN   1,864.27 (-0.73%)
CGC   24.57 (+1.11%)
BABA   226.09 (+0.96%)
MU   57.13 (-0.95%)
GE   11.81 (-0.34%)
TSLA   509.77 (-0.72%)
AMD   50.48 (+1.41%)
T   38.34 (+0.79%)
ACB   2.10 (-2.33%)
F   9.17 (-0.11%)
NFLX   338.31 (-0.09%)
BAC   34.65 (-0.20%)
GILD   62.98 (-0.35%)
DIS   144.97 (-0.10%)
S&P 500   3,322.57 (+0.17%)
DOW   29,319.84 (+0.08%)
QQQ   222.43 (+0.07%)
AAPL   315.89 (+0.21%)
MSFT   165.52 (-0.39%)
GOOGL   1,464.15 (+0.96%)
AMZN   1,864.27 (-0.73%)
CGC   24.57 (+1.11%)
BABA   226.09 (+0.96%)
MU   57.13 (-0.95%)
GE   11.81 (-0.34%)
TSLA   509.77 (-0.72%)
AMD   50.48 (+1.41%)
T   38.34 (+0.79%)
ACB   2.10 (-2.33%)
F   9.17 (-0.11%)
NFLX   338.31 (-0.09%)
BAC   34.65 (-0.20%)
GILD   62.98 (-0.35%)
DIS   144.97 (-0.10%)
S&P 500   3,322.57 (+0.17%)
DOW   29,319.84 (+0.08%)
QQQ   222.43 (+0.07%)
AAPL   315.89 (+0.21%)
MSFT   165.52 (-0.39%)
GOOGL   1,464.15 (+0.96%)
AMZN   1,864.27 (-0.73%)
CGC   24.57 (+1.11%)
BABA   226.09 (+0.96%)
MU   57.13 (-0.95%)
GE   11.81 (-0.34%)
TSLA   509.77 (-0.72%)
AMD   50.48 (+1.41%)
T   38.34 (+0.79%)
ACB   2.10 (-2.33%)
F   9.17 (-0.11%)
NFLX   338.31 (-0.09%)
BAC   34.65 (-0.20%)
GILD   62.98 (-0.35%)
DIS   144.97 (-0.10%)
S&P 500   3,322.57 (+0.17%)
DOW   29,319.84 (+0.08%)
QQQ   222.43 (+0.07%)
AAPL   315.89 (+0.21%)
MSFT   165.52 (-0.39%)
GOOGL   1,464.15 (+0.96%)
AMZN   1,864.27 (-0.73%)
CGC   24.57 (+1.11%)
BABA   226.09 (+0.96%)
MU   57.13 (-0.95%)
GE   11.81 (-0.34%)
TSLA   509.77 (-0.72%)
AMD   50.48 (+1.41%)
T   38.34 (+0.79%)
ACB   2.10 (-2.33%)
F   9.17 (-0.11%)
NFLX   338.31 (-0.09%)
BAC   34.65 (-0.20%)
GILD   62.98 (-0.35%)
DIS   144.97 (-0.10%)
Log in

NASDAQ:AKRX - Akorn Stock Price, Forecast & News

$1.38
-0.03 (-2.13 %)
(As of 01/17/2020 12:01 PM ET)
Today's Range
$1.37
Now: $1.38
$1.48
50-Day Range
$1.25
MA: $2.34
$3.84
52-Week Range
$1.19
Now: $1.38
$5.46
Volume40,303 shs
Average Volume3.64 million shs
Market Capitalization$174.08 million
P/E RatioN/A
Dividend YieldN/A
Beta1.69
Akorn, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNASDAQ:AKRX
CUSIP00972810
CIK3116
Phone847-279-6100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$694.02 million
Cash Flow$0.33 per share
Book Value$3.54 per share

Profitability

Net Income$-401,910,000.00

Miscellaneous

Employees2,191
Market Cap$174.08 million
Next Earnings DateN/A
OptionableOptionable

Receive AKRX News and Ratings via Email

Sign-up to receive the latest news and ratings for AKRX and its competitors with MarketBeat's FREE daily newsletter.


Revealed... The Top 3 Stocks for 2020 (Ad)


Investors looking for the best way to potentially double their money in 2020 -- regardless of whether the overall markets are up or down -- should look no further than these 3 unique stocks.

This Special Report reveals the names of these stocks and provides everything you need to invest right away.

Akorn (NASDAQ:AKRX) Frequently Asked Questions

What is Akorn's stock symbol?

Akorn trades on the NASDAQ under the ticker symbol "AKRX."

How were Akorn's earnings last quarter?

Akorn, Inc. (NASDAQ:AKRX) issued its earnings results on Thursday, October, 31st. The company reported $0.02 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.04) by $0.06. The firm earned $176.24 million during the quarter, compared to analysts' expectations of $176.15 million. Akorn had a negative net margin of 53.62% and a negative return on equity of 19.95%. The firm's revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted ($0.06) earnings per share. View Akorn's Earnings History.

What price target have analysts set for AKRX?

3 Wall Street analysts have issued 12-month target prices for Akorn's stock. Their forecasts range from $4.00 to $8.00. On average, they anticipate Akorn's stock price to reach $5.67 in the next twelve months. This suggests a possible upside of 310.6% from the stock's current price. View Analyst Price Targets for Akorn.

What is the consensus analysts' recommendation for Akorn?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akorn in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Akorn.

Has Akorn been receiving favorable news coverage?

Media headlines about AKRX stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Akorn earned a media sentiment score of 2.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Akorn.

Are investors shorting Akorn?

Akorn saw a decline in short interest in the month of December. As of December 31st, there was short interest totalling 5,820,000 shares, a decline of 31.6% from the December 15th total of 8,510,000 shares. Based on an average trading volume of 2,180,000 shares, the short-interest ratio is presently 2.7 days. Currently, 6.2% of the company's shares are sold short. View Akorn's Current Options Chain.

Who are some of Akorn's key competitors?

What other stocks do shareholders of Akorn own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akorn investors own include Celgene (CELG), Integrated Device Technology (IDTI), Skechers USA (SKX), Rite Aid (RAD), Lannett (LCI), Bank of America (BAC), Quantenna Communications (QTNA), Ulta Beauty (ULTA), Paycom Software (PAYC) and Square (SQ).

Who are Akorn's key executives?

Akorn's management team includes the folowing people:
  • Mr. Duane A. Portwood, Exec. VP & CFO (Age 53)
  • Mr. Joseph Bonaccorsi, Exec. VP, Gen. Counsel & Sec. (Age 54)
  • Mr. Jonathan Kafer, Exec. VP & Chief Commercial Officer (Age 56)
  • Dr. Bruce Kutinsky, Consultant (Age 53)
  • Mr. Douglas S. Boothe, Pres, CEO & Direcor (Age 55)

How do I buy shares of Akorn?

Shares of AKRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Akorn's stock price today?

One share of AKRX stock can currently be purchased for approximately $1.38.

How big of a company is Akorn?

Akorn has a market capitalization of $174.08 million and generates $694.02 million in revenue each year. The company earns $-401,910,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis. Akorn employs 2,191 workers across the globe.View Additional Information About Akorn.

What is Akorn's official website?

The official website for Akorn is http://www.akorn.com/.

How can I contact Akorn?

Akorn's mailing address is 1925 WEST FIELD COURT SUITE 300, LAKE FOREST IL, 60045. The company can be reached via phone at 847-279-6100 or via email at [email protected]


MarketBeat Community Rating for Akorn (NASDAQ AKRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  536 (Vote Outperform)
Underperform Votes:  463 (Vote Underperform)
Total Votes:  999
MarketBeat's community ratings are surveys of what our community members think about Akorn and other stocks. Vote "Outperform" if you believe AKRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AKRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel